Download Free Sample Report

Orlistat Market, Global Outlook and Forecast 2023-2032

Orlistat Market, Global Outlook and Forecast 2023-2032

  • Published on : 03 October 2023
  • Pages :77
  • Report Code:SMR-7822046

Download Report PDF Instantly

Leave This Empty:

Secure

Report overview

The global Orlistat market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.

This report aims to provide a comprehensive presentation of the global market for Orlistat, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Orlistat. This report contains market size and forecasts of Orlistat in global, including the following market information:

  • Global Orlistat Market Revenue, 2018-2023, 2024-2032, ($ millions)
  • Global Orlistat Market Sales, 2018-2023, 2024-2032, (K Pcs)
  • Global top five Orlistat companies in 2022 (%)
The U.S. Market is Estimated at $ Million in 2022, While China is Forecast to Reach $ Million.
120mg Orlistat Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Orlistat include Roche, GSK group, Teva, Sandoz(Novartis), STADA-VN J.V.Co., Ltd, Hexal AG, National Company for Pharmaceutical Industry, Lunan Pharmaceutical Group Corporation and ZEIN pharmaceutical, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We has surveyed the Orlistat manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Orlistat Market, by Type, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Orlistat Market Segment Percentages, by Type, 2022 (%)
  • 120mg Orlistat
  • 60mg Orlistat
Global Orlistat Market, by Application, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Orlistat Market Segment Percentages, by Application, 2022 (%)
  • Weight-reducing Aid
  • Other
Global Orlistat Market, By Region and Country, 2018-2023, 2024-2032 ($ Millions) & (K Pcs)
Global Orlistat Market Segment Percentages, By Region and Country, 2022 (%)
  • North America (United States, Canada, Mexico)
  • Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, India, Japan, South Korea, Australia, Rest of APAC)
  • The Middle East and Africa (Middle East, Africa)
  • South and Central America (Brazil, Argentina, Rest of SCA)

Competitor Analysis

The report also provides analysis of leading market participants including:
  • Key companies Orlistat revenues in global market, 2018-2023 (Estimated), ($ millions)
  • Key companies Orlistat revenues share in global market, 2022 (%)
  • Key companies Orlistat sales in global market, 2018-2023 (Estimated), (K Pcs)
  • Key companies Orlistat sales share in global market, 2022 (%)

key players include:

  • Roche
  • GSK group
  • Teva
  • Sandoz(Novartis)
  • STADA-VN J.V.Co., Ltd
  • Hexal AG
  • National Company for Pharmaceutical Industry
  • Lunan Pharmaceutical Group Corporation
  • ZEIN pharmaceutical
  • HISUN
  • Taj Pharmaceuticals Ltd
  • Kabir Life Sciences & Research
  • DM Pharma
  • China Zhongshan Pharm
Outline of Major Chapters:
Chapter 1: Introduces the definition of Orlistat, market overview.
Chapter 2: Global Orlistat market size in revenue and volume.
Chapter 3: Detailed analysis of Orlistat manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Orlistat in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: Global Orlistat capacity by region & country.
Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 10: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 11: The main points and conclusions of the report.